Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Apr 21, 2021

5250_rns_2021-04-21_56c20f69-4e9e-439a-be4a-85ef8be1f889.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 20 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,708,247 1.32% 165,008 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,100 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,786,706 1.39% 178,208 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 238.0300 USD
Purchase 10 238.6000 USD
Purchase 15 238.5400 USD
Purchase 34 237.9475 USD
Purchase 45 238.5500 USD
Purchase 69 238.0000 USD
Purchase 89 238.1007 USD
Purchase 96 238.2000 USD
Purchase 100 237.7000 USD
Purchase 100 238.5900 USD
Purchase 100 238.0400 USD
Purchase 107 236.5523 USD
Purchase 400 238.0500 USD
Purchase 550 237.5909 USD
Purchase 682 238.1680 USD
Purchase 800 237.4287 USD
Purchase 800 238.0812 USD
Purchase 1,105 237.5796 USD
Purchase 1,108 238.1110 USD
Purchase 1,356 238.3521 USD
Purchase 1,862 238.0516 USD
Purchase 2,734 237.9299 USD
Purchase 4,300 238.5530 USD
Purchase 4,436 237.9873 USD
Purchase 5,233 238.0582 USD
Purchase 5,323 238.6133 USD
Purchase 5,735 238.5771 USD
Purchase 6,092 238.0360 USD
Purchase 6,445 237.2308 USD
Purchase 7,173 238.0269 USD
Purchase 11,402 237.2300 USD
Purchase 13,406 237.9586 USD
Purchase 31,274 237.6459 USD
Sale 1 237.4300 USD
Sale 15 237.9150 USD
Sale 20 238.5500 USD
Sale 34 237.9475 USD
Sale 50 238.5470 USD
Sale 92 236.4451 USD
Sale 101 237.9703 USD
Sale 116 237.7541 USD
Sale 200 238.0400 USD
Sale 299 237.8367 USD
Sale 336 237.9634 USD
Sale 700 238.0957 USD
Sale 833 238.1205 USD
Sale 989 237.5592 USD
Sale 1,633 237.9969 USD
Sale 2,435 238.0049 USD
Sale 5,868 237.9672 USD
Sale 6,445 237.2308 USD
Sale 6,773 238.0275 USD
Sale 7,847 238.0461 USD
Sale 10,219 237.9415 USD
Sale 10,508 238.3340 USD
Sale 11,504 237.2300 USD
Sale 35,964 237.6871 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 21 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005575/en/

BARCLAYS PLC